|
VYNE | Vyne Therapeutics Inc. |
|
|
VYNE | Vyne Therapeutics Inc. |
| Pharmaceutical Preparations |
| Book value per $ invested | $ 4.26 |
| Leverage | 22.04% |
| Market Cap | $ 34.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -42.1m |
| Margin | -1082.82% |
VYNE Therapeutics Inc., a pharmaceutical company, focuses on developing and commercializing various therapies for dermatology. The company is headquartered in Bridgewater, New Jersey.